Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · IEX Real-Time Price · USD
0.401
+0.001 (0.25%)
At close: May 17, 2024, 4:00 PM
0.410
+0.009 (2.22%)
After-hours: May 17, 2024, 7:58 PM EDT

Company Description

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.

It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.

The company was incorporated in 1999 and is based in San Diego, California.

Aethlon Medical, Inc.
Aethlon Medical logo
Country United States
Industry Medical Devices
Sector Healthcare
Employees 15
CEO James B. Frakes M.B.A.

Contact Details

Address:
11555 Sorrento Valley Road, Suite 203
San Diego, California 92121
United States
Phone 858-459-7800
Website aethlonmedical.com

Stock Details

Ticker Symbol AEMD
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0000882291
CUSIP Number 00808Y307
ISIN Number US00808Y4061
Employer ID 13-3632859
SIC Code 3841

Key Executives

Name Position
Guy F. Cipriani BS (Eng.), MBA Chief Operating Officer
Dr. Steven P. LaRosa M.D. Chief Medical Officer
James B. Frakes M.B.A. Interim Chief Executive Officer, Chief Financial Officer, Secretary and Director
Dr. Lee D. Arnold Ph.D. Chief Scientific Officer

Latest SEC Filings

Date Type Title
May 17, 2024 8-K Current Report
May 16, 2024 EFFECT Notice of Effectiveness
May 16, 2024 424B4 Prospectus
May 15, 2024 EFFECT Notice of Effectiveness
May 15, 2024 POS AM Post-Effective amendments for registration statement
May 13, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
May 10, 2024 8-K Current Report
Apr 25, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Apr 25, 2024 8-K Current Report
Apr 5, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933